DelveInsight’s, “Nonalcoholic Steatohepatitis Pipeline Insight” report provides comprehensive insights about 80+ companies ...
Adults and adolescents treated with icotrokinra experienced improvements in their moderate to severe plaque psoriasis, ...
NAD+ boosters can affect how certain medications like insulin, blood pressure lowering, antidepressants, and cancer ...
The common diabetes drug metformin works partly by excreting sugar from the bloodstream into the intestines, where gut ...
A study from Tübingen reveals that the brain plays a central role in the development of obesity. The prevalence of obesity ...
Researchers from the German Diabetes Center (DDZ) and the Heinrich Heine University Düsseldorf (HHU) have studied the ...
Why understanding the differences between Type 1 and Type 2 diabetes is essential for better health management and effective ...
A new study reveals that consuming high-calorie, highly processed foods for just five days can reduce the brain's sensitivity ...
Scientists in China have found a new potential drug target for weight loss. Blocking a protein called CD44 has been shown to ...
Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will feature two oral presentations, one poster presentation, and chair ...
Insulin is a hormone that allows glucose in the blood to enter cells, providing them with the energy to function. A lack of adequate insulin plays a key role in the development of diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results